Partner & Employee Best Access
First time users must log in to Best Access via the Virtual Environment, not via this link.


Apr 4, 2014

The Copaxone Story in the U.S. and India: An Update

As an update to our March 5th posting, The Copaxone Story in the U.S. and India, the U.S. Supreme Court (Supreme Court) this week granted Teva Pharmaceutical Industries Ltd.'s (Teva) writ of certiorari to review the Federal Circuit's decision invalidating several of Teva's patents covering its multiple sclerosis drug, Copaxone®. Background On December 27, 2007, […]
back to top